What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

NCT04436978 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Myocardial Infarction
Atrial Fibrillation
Atrial Flutter
STEMI - ST Elevation Myocardial Infarction
NSTEMI - Non-ST Segment Elevation MI
Bleeding
Stroke
Stent Thrombosis
Embolism
Coronary Artery Disease

Interventions

DRUG: 30-day DAPT
DRUG: Guideline-directed therapy

Sponsor

St. Antonius Hospital

Collaborators

[object Object]